Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391

One of the basic causes of mortality in developed countries is cardiovascular disease,especially coronary heart disease. Control of blood cholesterol level is important to avoid cardiovascular disease. In this study the bioactive compound(s) of Monascus purpureus FTC5391 with hypocholesterolemic po...

全面介紹

Saved in:
書目詳細資料
主要作者: Ajdari, Zahra
格式: Thesis
語言:English
出版: 2012
主題:
在線閱讀:http://psasir.upm.edu.my/id/eprint/33315/1/FBSB%202012%2022R.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
id my-upm-ir.33315
record_format uketd_dc
spelling my-upm-ir.333152015-03-11T03:59:49Z Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391 2012-03 Ajdari, Zahra One of the basic causes of mortality in developed countries is cardiovascular disease,especially coronary heart disease. Control of blood cholesterol level is important to avoid cardiovascular disease. In this study the bioactive compound(s) of Monascus purpureus FTC5391 with hypocholesterolemic potential was investigated. In order to purify and identify the hypocholesterolemic bioactive agent of M. purpureus FTC5391 fermented product, cultivated via submerged fermentation in modified medium was sub-fractionated by solid phase extraction (SPE). The hypocholesterolemic active fraction in rats was selected for further purification by recycling preparative HPLC (RP-HPLC). The effective fraction significantly (P-value < 0.05) regulated the serum lipid-profile of hypercholesterolemic rats as compared with no treated control groups. This fraction increased the serum HDL-C (100%) and decreased the TC (42.6%), LDL-C (46%), TG (54.4%) levels as well as TC/HDL-C ratio (71.9%). Whereas, Atrovastatin, as a positive control, could regulate the rat serum lipid profile by increasing the serum HDL-C (37.5%) and decreasing the serum TC, LDL-C, TG levels and TC/HDL-C ratio 45.15%, 42%, 54.3% and 61.4%, respectively. MS spectrum of the pure effective fraction and its comparison with spectra library suggested the cyclopropane-carboxylic acid 4-dodecanoeil ester as a novel hypocholesterolemic agent. The obvious superiority of this novel compound to gulate the lipid profile in comparison to the atrovastatin and its ability to decrease the liver damage indicator enzymes, revealed the golden perspective of this novel molecule as a potent future hypocholesterolemic drug. Monascus purpureus Cardiovascular system - Diseases Blood cholesterol 2012-03 Thesis http://psasir.upm.edu.my/id/eprint/33315/ http://psasir.upm.edu.my/id/eprint/33315/1/FBSB%202012%2022R.pdf application/pdf en public phd doctoral Universiti Putra Malaysia Monascus purpureus Cardiovascular system - Diseases Blood cholesterol
institution Universiti Putra Malaysia
collection PSAS Institutional Repository
language English
topic Monascus purpureus
Cardiovascular system - Diseases
Blood cholesterol
spellingShingle Monascus purpureus
Cardiovascular system - Diseases
Blood cholesterol
Ajdari, Zahra
Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
description One of the basic causes of mortality in developed countries is cardiovascular disease,especially coronary heart disease. Control of blood cholesterol level is important to avoid cardiovascular disease. In this study the bioactive compound(s) of Monascus purpureus FTC5391 with hypocholesterolemic potential was investigated. In order to purify and identify the hypocholesterolemic bioactive agent of M. purpureus FTC5391 fermented product, cultivated via submerged fermentation in modified medium was sub-fractionated by solid phase extraction (SPE). The hypocholesterolemic active fraction in rats was selected for further purification by recycling preparative HPLC (RP-HPLC). The effective fraction significantly (P-value < 0.05) regulated the serum lipid-profile of hypercholesterolemic rats as compared with no treated control groups. This fraction increased the serum HDL-C (100%) and decreased the TC (42.6%), LDL-C (46%), TG (54.4%) levels as well as TC/HDL-C ratio (71.9%). Whereas, Atrovastatin, as a positive control, could regulate the rat serum lipid profile by increasing the serum HDL-C (37.5%) and decreasing the serum TC, LDL-C, TG levels and TC/HDL-C ratio 45.15%, 42%, 54.3% and 61.4%, respectively. MS spectrum of the pure effective fraction and its comparison with spectra library suggested the cyclopropane-carboxylic acid 4-dodecanoeil ester as a novel hypocholesterolemic agent. The obvious superiority of this novel compound to gulate the lipid profile in comparison to the atrovastatin and its ability to decrease the liver damage indicator enzymes, revealed the golden perspective of this novel molecule as a potent future hypocholesterolemic drug.
format Thesis
qualification_name Doctor of Philosophy (PhD.)
qualification_level Doctorate
author Ajdari, Zahra
author_facet Ajdari, Zahra
author_sort Ajdari, Zahra
title Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
title_short Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
title_full Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
title_fullStr Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
title_full_unstemmed Isolation and characterization of hypocholesterolemic bioactive agent extracted from Monascus purpureus FTC5391
title_sort isolation and characterization of hypocholesterolemic bioactive agent extracted from monascus purpureus ftc5391
granting_institution Universiti Putra Malaysia
publishDate 2012
url http://psasir.upm.edu.my/id/eprint/33315/1/FBSB%202012%2022R.pdf
_version_ 1747811692130074624